The gut microbiota and the liver: implications for clinical practice (Q35019661)

5 August 2017

The gut microbiota and the liver: implications for clinical practice (English)

1 reference

5 August 2017

Eamonn M Quigley

1

1 reference

PubMed ID

24134195

5 August 2017

Howard P Monsour

series ordinal

2

1 reference

5 August 2017

18 October 2013

1 reference

Expert Review of Gastroenterology & Hepatology

5 August 2017

1 reference

5 August 2017

7

1 reference

5 August 2017

723-732

1 reference

5 August 2017

8

1 reference

Techniques used to characterize the gut microbiota: a guide for the clinician.

5 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

The role of the gut microbiota in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Role of gut microbiota in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Dietary Factors: Major Regulators of the Gut's Microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

The gut microbiota and its relationship to diet and obesity: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

High-fat diet determines the composition of the murine gut microbiome independently of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Long-term ecological impacts of antibiotic administration on the human intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut microbiota composition correlates with diet and health in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Antibiotics in early life alter the murine colonic microbiome and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Colonic microbiome is altered in alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut-liver axis and sensing microbes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Hepatobiliary complications of total parenteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Infection, coagulation, and variceal bleeding in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

The liver as a lymphoid organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Therapeutic strategies in inflammasome mediated diseases of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Intestinal bacterial translocation in rats with cirrhosis is related to compromised Paneth cell antimicrobial host defense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Characterization of fecal microbial communities in patients with liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Linkage of gut microbiome with cognition in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Changes of fecal Bifidobacterium species in adult patients with hepatitis B virus-induced chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

A core gut microbiome in obese and lean twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Obesity alters gut microbial ecology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut metagenome in European women with normal, impaired and diabetic glucose control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Functional characterization of TLR4 +3725 G/C polymorphism and association with protection against overweight

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis--a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Intestinal microbiota in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut microbiota and probiotics in chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Relation between Escherichia coli R(rough)-forms in gut, lipid A in liver, and primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut microbiota-derived propionate reduces cancer cell proliferation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Gut flora and bacterial translocation in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Nitric oxide and the hyperdynamic circulation in cirrhosis: is there a role for selective intestinal decontamination?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Rifaximin treatment in hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Prevention and treatment of hepatic encephalopathy: focusing on gut microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Systematic review: medical and nutritional interventions for the management of intestinal failure and its resultant complications in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Endotoxin- and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Probiotics in hepatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Probiotics and gut health: a special focus on liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

The core gut microbiome, energy balance and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.848167

10.1586/17474124.2013.848167

21 January 2018

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

24134195